Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Angiplast Private Limited
WARNING LETTER
•Angiplast Private Limited•January 30, 2020

Angiplast Private Limited – FDA Warning Letter, Jan 30, 2020

Record Details

On May 14, 2020, the FDA issued a Warning Letter to a firm in Ahmedbad, India, following an inspection from January 27-30, 2020. The inspection revealed that the firm's urinary drainage bags, classified as medical devices, were adulterated under section 501(h) of the Act, as their manufacturing, packing, storage, or installation methods did not conform to the Quality System regulation (21 CFR Part 820).

Key violations included: 1. **Failure to establish and maintain procedures for acceptance of incoming product (21 CFR 820.80(b))**: Five of nine PVC inlet tube lots for urinary drain bags did not meet specified length or weight criteria but were accepted and used in finished devices. The firm's response, which involved increasing tolerance and not addressing nonconforming product identification or past records, was deemed inadequate. 2. **Failure to establish and maintain procedures for corrective and preventive action (21 CFR 820.100(a))**: * The CAPA procedure did not define how statistical methodology would be employed, and no statistical analysis was performed. The firm's revised procedure was unclear on implementation and rationale for sampling frequency. * CAPA 02/2017-18 was closed without verification of effectiveness. The revised procedure did not ensure

Company
Angiplast Private Limited
Inspection date
January 30, 2020
Product type
Devices
Office
Center for Devices and Radiological Health
People
  • Benjamin R. Fisher (Office Director)
  • Earl G. Christensen
View Company Profile

ID · 82e6ec99-87a4-44c1-8b00-8912ba773b94

Violation Codes7
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.80(b)21 CFR 820.100(a)21 CFR 820.50(a)(1)21 CFR 820.75(b)

Full citation text and observation details available on the Dashboard.

Other documents for Angiplast Private Limited
  • 483 - 2020-01-30January 30, 2020

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Angiplast Private Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.